Jasmin Taubenschmid

Jasmin Taubenschmid

Auto-generated profile, based on publicly available information

Jasmin Taubenschmid

Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
RWReiner A. Wimmer
Reiner A. Wimmer
ALAlexandra Leopoldi
Alexandra Leopoldi
MAMartin Aichinger
Martin Aichinger
NWNikolaus Wick
Nikolaus Wick
BHBrigitte Hantusch
Brigitte Hantusch
JPJosef M Penninger
Josef M Penninger

1 December 2011 in Cell Stem Cell
Verified
Journal Article
Closed access
UEUlrich Elling
Ulrich Elling
JTJasmin Taubenschmid
Jasmin Taubenschmid
GWGerald Wirnsberger
Gerald Wirnsberger
RORonan O'MAlley
Ronan O'MAlley
SDSimon-Pierre Demers
Simon-Pierre Demers
JPJosef M Penninger
Josef M Penninger

24 February 2022 in Cell Stem Cell
Verified
Journal Article
Open access
JTJasmin Taubenschmid-Stowers
Jasmin Taubenschmid-Stowers
MRMaria Rostovskaya
Maria Rostovskaya
FSFátima Santos
Fátima Santos
SLSebastian Ljung
Sebastian Ljung
RARicard Argelaguet
Ricard Argelaguet
WRWolf Reik
Wolf Reik
The activation of the embryonic genome marks the first major wave of transcription in the developing organism. Zygotic genome activation (ZGA) in mouse 2-cell embryos and 8-cell embryos in humans is crucial for development. Here, we report the discovery of human 8-cell-like cells (8CLCs) among naive embryonic stem cells, which transcriptionally resemble the 8-cell human embryo. They express ZGA markers, including ZSCAN4 and LEUTX, and transposable elements, such as HERVL and MLT2A1. 8CLCs show reduced SOX2 levels and can be identified using TPRX1 and H3.Y marker proteins in vitro. Overexpression of the transcription factor DUX4 and spliceosome inhibition increase human ZGA-like transcription. Excitingly, the 8CLC markers TPRX1 and H3.Y are also expressed in ZGA-stage 8-cell human embryos and may thus be relevant in vivo. 8CLCs provide a unique opportunity to characterize human ZGA-like transcription and might provide critical insights into early events in embryogenesis in humans.

20 September 2017 in Nature
Verified
Journal Article
Closed access
PDF file
JSJohannes Stadlmann
Johannes Stadlmann
JTJasmin Taubenschmid
Jasmin Taubenschmid
DWDaniel Wenzel
Daniel Wenzel
AGAnna Gattinger
Anna Gattinger
GDGerhard Dürnberger
Gerhard Dürnberger
JPJosef M Penninger
Josef M Penninger

4 November 2022 in Science Advances
Verified
Journal Article
Open access
AHAstrid Hagelkruys
Astrid Hagelkruys
MHMarion Horrer
Marion Horrer
JTJasmin Taubenschmid-Stowers
Jasmin Taubenschmid-Stowers
AKAnoop Kavirayani
Anoop Kavirayani
MNMaria Novatchkova
Maria Novatchkova
JPJosef M Penninger
Josef M Penninger
The HUSH (human silencing hub) complex contains the H3K9me3 binding protein M-phase phosphoprotein 8 (MPP8) and recruits the histone methyltransferase SETDB1 as well as Microrchidia CW-type zinc finger protein 2 (MORC2). Functional and mechanistic studies of the HUSH complex have hitherto been centered around SETDB1 while the in vivo functions of MPP8 and MORC2 remain elusive. Here, we show that genetic inactivation of Mphosph8 or Morc2a in the nervous system of mice leads to increased brain size, altered brain architecture, and behavioral changes. Mechanistically, in both mouse brains and human cerebral organoids, MPP8 and MORC2 suppress the repetitive-like protocadherin gene cluster in an H3K9me3-dependent manner. Our data identify MPP8 and MORC2, previously linked to silencing of repetitive elements via the HUSH complex, as key epigenetic regulators of protocadherin expression in the nervous system and thereby brain development and neuronal individuality in mice and humans.

19 September 2017 in Cell Research
Verified
Journal Article
Open access
PDF file
JTJasmin Taubenschmid
Jasmin Taubenschmid
JSJohannes Stadlmann
Johannes Stadlmann
MJMarkus Jost
Markus Jost
TKTove Irene Klokk
Tove Irene Klokk
CRCory D Rillahan
Cory D Rillahan
JPJosef M Penninger
Josef M Penninger
Ricin is one of the most feared bioweapons in the world due to its extreme toxicity and easy access. Since no antidote exists, it is of paramount importance to identify the pathways underlying ricin toxicity. Here, we demonstrate that the Golgi GDP-fucose transporter Slc35c1 and fucosyltransferase Fut9 are key regulators of ricin toxicity. Genetic and pharmacological inhibition of fucosylation renders diverse cell types resistant to ricin via deregulated intracellular trafficking. Importantly, cells from a patient with SLC35C1 deficiency are also resistant to ricin. Mechanistically, we confirm that reduced fucosylation leads to increased sialylation of Lewis X structures and thus masking of ricin-binding sites. Inactivation of the sialyltransferase responsible for modifications of Lewis X (St3Gal4) increases the sensitivity of cells to ricin, whereas its overexpression renders cells more resistant to the toxin. Thus, we have provided unprecedented insights into an evolutionary conserved modular sugar code that can be manipulated to control ricin toxicity.